Mechanism of Kidney-tonifying and Anti-aging Chinese Medicines Combined with Stem Cell Therapy in Treatment of Alzheimer's Disease： A Review
10.13422/j.cnki.syfjx.20220790
- VernacularTitle:补肾抗衰类中药联合干细胞疗法治疗阿尔茨海默病的机制研究进展
- Author:
Shibiao SUN
1
;
Xiaolong PAN
1
;
Zhihui WEI
1
;
Feixiang LIU
2
;
Yunke ZHANG
1
Author Information
1. Henan University of Chinese Medicine， Zhengzhou 450000， China
2. The First Affiliated Hospital of Henan University of Chinese Medicine， Zhengzhou 450000， China
- Publication Type:Review
- Keywords:
Chinese medicine;
kidney-tonifying and anti-aging;
stem cell therapy;
Alzheimer's disease;
mechanism;
overview
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(15):199-211
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer's disease （AD） is a neurodegenerative disease associated with aging and age-related cognitive decline. It is characterized by insidious onset and progressive development， and has become a major global health and socioeconomic issue. The exact mechanisms underlying AD have not been fully elucidated， and various hypotheses have been proposed by researchers based on different etiologies， including the amyloid β （Aβ） cascade hypothesis， Tau protein hyperphosphorylation hypothesis， mitochondrial dysfunction and oxidative stress hypothesis， and neurotransmitter hypothesis. Therefore， there is an urgent need for comprehensive interventions targeting multiple pathways， links， and targets. Based on traditional Chinese medicine （TCM） theory and modern research findings， kidney-tonifying and anti-aging Chinese medicines have unique advantages of toxicity reduction， long-lasting effects， and treating both the root cause and the symptoms. They have been shown to counteract immune-inflammatory responses， clear reactive oxygen species， exhibit antioxidant properties， inhibit abnormal aggregation of Aβ and Tau proteins， reduce neuronal apoptosis， regulate central neurotransmitters， and modulate gut microbiota in AD. In recent years， stem cell therapy has been explored for the treatment of AD through two strategies： endogenous activation and exogenous transplantation， thereby replenishing and replacing damaged neurons. However， factors such as blood-brain barrier permeability， targeted delivery to the affected area， immune rejection， and cell survival rate can affect the efficacy of stem cell transplantation. Therefore， combining stem cell therapy with medication and other methods can further enhance the effectiveness of stem cell transplantation. Kidney-tonifying and anti-aging Chinese medicines can activate dormant neural stem cells（NSCs） in the body， promote neuroregeneration， and facilitate tissue and organ repair and reconstruction in AD. The combined treatment of these Chinese medicines and stem cell transplantation has shown more significant efficacy compared to either treatment alone. This combination therapy provides a new integration point for the modernization of TCM and offers new ideas and approaches for the prevention and treatment of AD， as well as improving the effectiveness of stem cell transplantation.
